The number of high growth enterprises in pharmaceutical preparations in Turkey experienced various fluctuations from 2014 through 2023. Starting at 60 units in 2014, there was a notable increase of 33.33% in 2015, peaking at 80 units. However, subsequent years saw declines, dropping to 67 units by 2017. A slight recovery occurred, with anomalies such as the 11.27% decline in 2020. By 2023, the number reached 71 units, with a year-on-year rise of 2.9% and a five-year CAGR of 1.47%.
Looking ahead, forecast data suggests stability around 71 units up to 2027, with a slight increase to 72 units in 2028, indicating a forecast five-year CAGR of 0.28%.
Future trends to watch for include potential impacts from technological advancements, regulatory changes, or shifts in global pharmaceutical demand, which can influence the number of high growth enterprises in Turkey's pharmaceutical sector.
